Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India flag India · Delayed Price · Currency is INR
1,310.00
-8.50 (-0.64%)
May 22, 2026, 3:29 PM IST

Dr. Reddy's Laboratories Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,088,2861,044,616953,1681,024,969767,655714,500
Market Cap Growth
11.41%9.59%-7.00%33.52%7.44%-4.65%
Enterprise Value
1,081,2071,033,149948,175972,270736,818707,464
Last Close Price
1307.201254.901136.991216.61906.23836.33
PE Ratio
25.4024.3816.8618.4117.0330.32
PS Ratio
3.243.112.933.673.123.33
PB Ratio
2.862.752.833.653.323.75
P/TBV Ratio
4.204.034.244.283.924.50
P/FCF Ratio
32.5631.2550.3735.3116.1453.13
P/OCF Ratio
19.1818.4120.5322.5613.0425.42
EV/Sales Ratio
3.223.082.913.483.003.30
EV/EBITDA Ratio
15.3114.6510.6712.2611.1614.82
EV/EBIT Ratio
21.6120.7012.9814.8213.7919.70
EV/FCF Ratio
32.3430.9150.1033.4915.5052.61
Debt / Equity Ratio
0.200.200.140.070.060.18
Debt / EBITDA Ratio
1.101.100.520.250.200.71
Debt / FCF Ratio
2.312.312.470.690.282.52
Net Debt / Equity Ratio
-0.03-0.03-0.03-0.22-0.21-0.05
Net Debt / EBITDA Ratio
-0.15-0.15-0.12-0.77-0.73-0.22
Net Debt / FCF Ratio
-0.31-0.31-0.59-2.12-1.02-0.78
Asset Turnover
0.630.630.740.790.800.77
Inventory Turnover
2.152.152.012.062.142.09
Quick Ratio
1.131.131.161.721.581.24
Current Ratio
1.801.801.922.582.381.93
Return on Equity (ROE)
11.83%11.83%18.53%21.77%21.38%12.96%
Return on Assets (ROA)
5.82%5.82%10.37%11.56%10.86%8.04%
Return on Invested Capital (ROIC)
10.58%11.11%19.98%25.30%21.99%15.03%
Return on Capital Employed (ROCE)
12.10%12.10%20.10%22.50%22.60%18.10%
Earnings Yield
3.94%4.10%5.93%5.43%5.87%3.30%
FCF Yield
3.07%3.20%1.98%2.83%6.19%1.88%
Dividend Yield
0.60%0.64%0.70%0.66%0.88%0.72%
Payout Ratio
15.54%15.54%11.78%11.94%11.05%17.59%
Buyback Yield / Dilution
0.10%0.10%-0.08%-0.19%-0.03%-0.01%
Total Shareholder Return
0.70%0.74%0.63%0.47%0.85%0.70%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.